News
-
Prevention strategies for all: Launch of the 2025 Canadian HIV PEP & PrEP Guideline
Led by Dr. Darrell Tan and supported by the CTN+, this document provides the most update-to-date evidence for…
-
How small changes are making big strides in prison harm reduction
One in four people in Canadian federal prisons have been previously exposed to hepatitis C. Hepatitis C can…
-
Welcoming the 2025 Cohort of CTN+ Postdoctoral Fellows
The CTN+ is dedicated to supporting HIV and STBBI research across Canada, and a crucial part of that…
-
Postdoc Spotlight: Hajar Miranzadeh
Hajar Miranzadeh moved to Canada in 2015 to start her PhD in Pharmacology at the University of Saskatchewan.…
-
-
Postdoc Spotlight: Dr. Katherine Kooij
Dr. Katherine Kooij, a medical doctor and epidemiologist, started her CTN fellowship in 2022. Her interest in HIV…
-
Postdoc Spotlight: Dr. Alice Zhabokritsky
Dr. Alice Zhabokritsky embarked on her CTN fellowship in the summer of 2021 upon completion of her infectious…
-
Putting data into action: How CTN researchers track, prevent, and manage HIV in infants
The Canadian Pediatric and Perinatal HIV/AIDS Research Group is a collection of clinicians and researchers that form the…
-
Guest blog: Dr. Oscar Javier Pico Espinosa
CTN Postdoctoral Fellow Dr. Oscar Javier Pico Espinosa shares his journey to becoming a researcher in the HIV…
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
-
Resource CategoriesTypes
CATIE
CATIE’s HIV and Hepatitis C Testing course aims to develop in-depth knowledge of testing technologies, approaches to testing, and how all service providers play an important role in reaching people with HIV and hepatitis C. Throughout this course, participants learn about the importance of testing for HIV and hepatitis C, what testing technologies exist in…
-
Resource CategoriesTypes
CATIE
This course aims to develop in-depth knowledge of HIV treatment for frontline service providers. Participants learn how HIV treatment works in the body, what being on HIV treatment means, how HIV develops drug resistance and how to support clients with adherence.
-
Resource Categories
PHAC
HIV in Canada: 2022 surveillance highlights
-
Resource CategoriesTypes
PHAC
The Public Health Agency of Canada’s integrated bio-behavioural surveillance system—Tracks surveys—assesses the burden of HIV, hepatitis C and associated risks in key populations in Canada
-
Resource CategoriesTypes
PHAC
Summary of the provincial and territorial coverage of antiretroviral therapy in Canada. Data was collected from secondary data sources between September and December 2022
-
Types
CTN+
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
-
Types
CTN+
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTNPT 055: Testing Immunogenicity and Durability of Mpox Vaccination in People Living with HIV
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
-
CTN 343: Project ReportNeedles.ca
Project ReportNeedles.ca: A rapid assessment and response system to map needle prevalence and implement harm reduction interventions in Regina, Saskatchewan
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.